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S12 Infections in Patients with Solid Organ Transplantation
PCR profiles were found in lesions and blood, but 1 case with a
mixed infection had Tc II in chagomas and allograft heart and Tc
I in blood. RA patients were treated with benznidazole with neg-
ative PCR results and remission of clinical manifestations, but in
one case a second RA occurred 286 days after end of treatment.
Conclusions: Both lineages are linked to myocarditis causing ChD,
revealing a higher frequency of Tc I than expected for the southern
cone of America. Tc II displayed higher parasitemias than Tc I. Dif-
ferential histotropism occurred in pts with mixed infections. This
study also underlines the value of PCR for early diagnosis of RA and
monitoring of treatment efficacy.
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Background: Lung transplant recipients are at risk for opportunis-
tic infections as a result of potent immunosuppression targeting
cell-mediated immunity. However, neutropenia or neutrophil dys-
function is the main risk factor for many of the infections these
patients contract, including serious bacterial and invasive fungal
infections. We hypothesize that neutrophil function, as measured
by neutrophil respiratory burst (RB), is significantly decreased in
lung transplant recipients.
Materials/Methods: Fourteen lung transplant patients undergoing
routine phlebotomy were enrolled. Neutrophils were isolated from
the blood of patients and controls, brought to a standard concen-
tration of 1x107 cells per milliliter (mL), and stimulated with op-
sonized zymosan particles. Reaction mixtures of 100 microliters of
zymosan and neutrophil suspension and 500 microliters of lumi-
nol were analyzed with a luminometer. The amount of light given
off (chemiluminescence, CL), which is directly proportional to the
neutrophil RB per cell, was measured.
Results: Sixteen patient samples from 14 patients were tested (two
patients were tested twice). A control sample was evaluated with
each patient sample. One patient' s data was excluded, thus 15
patient samples from 14 separate patients were analyzed. Lung
transplant recipients had lower mean CL than controls (3.37x109
vs. 4.03x109). This difference was not statistically significant. 9/15
patient samples had normal CL values when compared to controls.
6/15 patient samples had CL values that were more than 1 stan-
dard deviation (SD) below the mean CL value for controls (Fisher' s
Abstract 26 – Figure 1. Enrollment schematic and respitarory burst results for lung transplant recipients.
Figure 2. Percentage of lung transplant recipients with normal and
decreased respiratory burst.
Exact Test, p=0.046). In fact, 3 of these 6 patient samples had CL
values that were more than 2 SD below this same mean, indicat-
ing severely decreased super-oxide production and RB capacity. All
6 patients with low CL values had no change in their risk of con-
current infection or rejection. There was no correlation between
CL and time from transplant, absolute neutrophil count, or T-cell
function, indicating that this test may be useful as an independent
marker of immune function.
Conclusions: Lung transplant recipients vary considerably with re-
spect to their RB capacity. Some patients have RB defects com-
parable to the defects seen in Chronic Granulomatous Disease of
Childhood, a disease characterized by low super-oxide production
and high rates of infection. Further studies are needed to evaluate
the role that RB defects play in infectious risk for this population.
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Associated Nephropathy
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Venetz, Pascal R. Meylan.. Centre Hospitalier Universitaire
Vaudois and University of Lausanne, Service of Infectious Diseases
and Transplantation Centre, Lausanne, Switzerland
Background: BK virus associated nephropathy occurs in 1-10% of
kidney transplant recipients and may be a cause of graft loss. This
infection is difficult to manage because of the absence of specific
therapy. Cidofovir, a DNA polymerase inhibitor approved for the
treatment of CMV retinitis, has shown in vitro activity against BK
virus and some clinical efficacy when used at low-dose in uncon-
trolled series.
